Picture of Rohto Pharmaceutical logo

4527 — Rohto Pharmaceutical News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Table: Rohto -2019/20 parent results

May 12 (Reuters)- 
          Rohto Pharmaceutical Co Ltd 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to     NEXT     
                Mar 31, 2020    Mar 31, 2019   Mar 31, 2021     YEAR     
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales            106.48          104.38                                
                 (+2.0 pct)      (+7.7 pct)                              
  Operating         13.26           13.01                                
                 (+1.9 pct)      (+1.2 pct)                              
  Recurring         14.37           15.19                                
                 (-5.4 pct)      (+2.3 pct)                              
  Net                6.98            4.82                                
                 (+44.9 pct)     (-36.9 pct)                             
  EPS             61.19 yen       42.26 yen                              
  EPS Diluted     61.00 yen       42.10 yen                              
  Ann Div         26.00 yen       25.00 yen      27.00 yen               
  -Q2 Div         13.00 yen       11.00 yen      13.00 yen               
  -Q4 Div         13.00 yen       14.00 yen      14.00 yen               
  
  NOTE - Rohto Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4527.T

Recent news on Rohto Pharmaceutical

See all news